PDF Summary:The Great Cholesterol Myth, by Jonny Bowden and Stephen Sinatra

For decades, conventional medical wisdom has told us that high cholesterol causes heart disease and that we should avoid saturated fats. But what if this understanding is fundamentally flawed? In The Great Cholesterol Myth, Jonny Bowden and Stephen Sinatra challenge the lipid hypothesis, arguing that cholesterol levels are not reliable predictors of heart attacks and that the real culprits behind cardiovascular disease are inflammation, oxidative stress, and insulin resistance.

The authors examine the evidence against the traditional cholesterol theory, explain why standard cholesterol tests are misleading, and discuss the limitations and side effects of statin drugs. They also explore how different types of saturated fats affect the body in distinct ways and introduce advanced markers that better assess cardiovascular risk. This summary provides a framework for understanding heart disease beyond the cholesterol narrative.

(continued)...

The authors further argue that eating saturated fat doesn’t predict cardiovascular disease risk. They cite a 2012 meta-analysis of 21 studies that found no link between consuming saturated fat and the likelihood of cardiovascular disease. They also mention a 2011 study that found that consuming saturated fat correlated with a small rise in total cholesterol, but not in cardiovascular disease. Additionally, they point to a 2014 meta-analysis of 32 studies that found consuming saturated fat doesn't raise the risk of heart disease.

(Shortform note: The American Heart Association (AHA) argues the opposite: that eating saturated fat does predict future heart problems. In a 2017 report, the AHA cited a meta-analysis of four randomized controlled trials that found that replacing animal fats with polyunsaturated vegetable oils reduced the risk of myocardial infarction (heart attack) by 30%. The AHA argues that this reduction in risk is similar to the reduction in risk that statins provide. The AHA also argues that the evidence for the link between saturated fat and heart disease is strong because it comes from randomized controlled trials, which are the gold standard of scientific research.)

Furthermore, Bowden and Sinatra highlight a 2015 meta-analysis that found no association between saturated fat intake and mortality from any cause, cardiovascular disease, coronary heart disease, ischemic stroke, or diabetes type 2. They also cite a 2016 review of data from the Minnesota Coronary Experiment, which found that replacing saturated fat with linoleic acid lowers cholesterol but doesn’t reduce the likelihood of dying due to coronary heart disease or any other reason. Finally, they mention a 2017 analysis that looked at a group of randomized controlled trials and found that replacing saturated fat with mostly n-6 polyunsaturated fat is unlikely to reduce coronary heart disease events, death rates from coronary heart disease, or total mortality, and an analysis of cohort studies that found consuming saturated fat doesn't elevate the risk of cardiovascular disease.

The AHA’s Position on Saturated Fat

Despite the evidence Bowden and Sinatra cite, the American Heart Association (AHA) continues to recommend limiting saturated fat intake to reduce cardiovascular risk. In a 2017 Presidential Advisory, the authors argue that lowering intake of saturated fat and replacing it with unsaturated fats, particularly polyunsaturated fats from vegetable oils, reduces cardiovascular disease events and should remain a central recommendation for cardiovascular risk reduction in clinical and public health practice. The authors cite multiple lines of evidence, including randomized controlled trials, prospective observational studies, and animal experiments, to support their position. They argue that replacing saturated fat with polyunsaturated fat reduces cardiovascular disease events, and that this effect is consistent across different types of studies and populations.

Statin Therapy: Limited Benefits and Potential Harms

Bowden and Sinatra argue that statins offer limited benefits and cause significant side effects. They say that statins are only appropriate for men of middle age who have a history of heart attack or a coronary artery disease diagnosis. While statins have been shown to lower rates of illness and death from heart issues in those highly at risk for developing coronary artery disease, they have many side effects, including pain and weakness in the muscles, tiredness, cognitive and memory issues, and sexual dysfunction. Additionally, statins deplete coenzyme Q10, an important nutrient for the heart, and lower cholesterol in the brain, impairing cellular communication and cognition. They also reduce sex hormones, which can cause sexual dysfunction, and may increase the risk of cancer and diabetes.

The Impact of Negative Media Coverage on Statin Use

While Bowden and Sinatra argue that statins are only appropriate in rare cases, medical researchers warn that negative media coverage of statins can lead to patients discontinuing their use, which can have serious consequences. In a study conducted in Denmark, researchers found that after negative media coverage of statins, there was a significant increase in the number of people who stopped taking them. The research showed that those who stopped taking statins had a higher risk of heart attack and death from cardiovascular disease compared to those who continued taking them. The researchers concluded that negative media coverage of statins can have a significant impact on public health, as it may lead to people discontinuing a medication that could potentially save their lives.

The True Drivers of Cardiovascular Disease: Inflammation, Insulin Resistance, and Oxidative Stress

Pathophysiological Mechanisms of Cardiovascular Disease

Bowden and Sinatra say that inflammation and LDL that has been oxidized are key contributors to cardiovascular disease. Oxidized LDL refers to LDL that's been harmed by free radicals, while inflammation is the immune system’s response to damage. The authors explain that oxidizing LDL is the main cause of atherosclerosis. LDL is harmless until it becomes oxidized, at which point it can slip through the endothelium and get stuck within artery walls.

(Shortform note: Since the publication of The Great Cholesterol Myth, the authors’ claim that LDL is harmless until it becomes oxidized has been refined. In 2017, a group of 30 scientists and doctors from around the world published a consensus statement on the role of LDL in cardiovascular disease. They concluded that the total amount of LDL in the body over time is the main cause of arterial injury, while factors like inflammation and oxidation determine how quickly and severely the disease progresses.)

This triggers an inflammatory response, which produces plaque and results in additional injury and inflammation. The immune system sends monocytes to the site of the damage, which release cytokines—chemical messengers that modulate immune response. Many cytokines are extremely pro-inflammatory. The monocytes then convert into macrophages, which consume the oxidized LDL particles. The macrophages continue to consume the oxidized LDL until they die, leaving behind the fatty center of the plaque. They also release toxins in the arteries. The inflammation process may swiftly turn into an unrestrained blaze inside your arteries.

(Shortform note: Monocytes are a type of white blood cell produced in the bone marrow. They circulate in the bloodstream and are part of the body’s innate immune defense system. Monocytes are the largest type of white blood cell and have a distinctive kidney-shaped nucleus. They play a crucial role in the immune system by responding to infections, inflammation, and tissue damage. Monocytes are part of the body’s first line of defense against pathogens and help initiate and regulate immune responses.)

Without inflammation, cholesterol quantity is irrelevant. The more diminutive the LDL particles, the more they cause inflammation. Pattern B LDL particles are compact and tiny, making them more likely to be oxidized and to get into the arterial walls, while Pattern A LDL particles are large and buoyant, making them less likely to be oxidized and to get into the arterial walls.

Origins of the LDL Particle Size Theory

The idea that cholesterol quantity is irrelevant and that small, dense LDL is more problematic than large, buoyant LDL is largely based on the work of Ronald M. Krauss, a prominent American lipidologist and researcher. Krauss's research in the late 20th century focused on the heterogeneity of LDL particles and their role in cardiovascular disease. Krauss developed techniques to separate LDL particles into subfractions based on size and density using gradient-gel electrophoresis. His work was motivated by observations that some individuals with normal cholesterol levels still experienced premature cardiovascular events, suggesting that traditional cholesterol measurements might not capture the full picture of cardiovascular risk.

Bowden and Sinatra also say that resistance to insulin is a significant risk for heart and vascular conditions. Insulin resistance occurs when the body's cells don't properly respond to insulin, which regulates blood glucose levels.

They explain that insulin resistance is central to a group of conditions that elevate risk for heart problems: hypertension, belly fat, low HDL cholesterol, and elevated triglycerides. It results in oxidative strain, inflammation, endothelial malfunction, high glucose levels, and cellular injury. It also results in elevated triglycerides, decreased HDL, and compact, dense LDL molecules. Additionally, insulin resistance is connected to obesity, which raises the likelihood of heart and vascular conditions.

Furthermore, Bowden and Sinatra say that resistance to insulin predicts heart disease and other chronic diseases. It’s also a predictor of plaque build-up in arteries, and addressing insulin resistance might avert over 40% of heart attacks.

Exception to the Rule: Familial Hypercholesterolemia

While insulin resistance is a major risk factor for heart disease, there are exceptions. For example, people with familial hypercholesterolemia (FH) have a genetic mutation that causes extremely high LDL cholesterol levels from birth. Even if they are lean and metabolically healthy, they can develop severe heart disease at a young age. This is because their LDL levels are so high that they overwhelm the body's ability to clear them, leading to rapid plaque buildup. So while insulin resistance is a key driver of heart disease for most people, there are rare cases where genetic factors can cause severe heart disease even in the absence of insulin resistance.

Dietary and Nutritional Influences on Cardiovascular Disease

Bowden and Sinatra argue that consuming saturated fats doesn't raise the risk of cardiovascular disease. They explain that saturated fats consist of various fatty acids, which all have distinct effects on cholesterol, metabolism, and health. They’re found mostly in animal foods and a few plant foods, and they’re stable and resistant to heat, air, and sun exposure.

The authors add that certain fats are beneficial. In fact, increased saturated fat consumption is linked to reduced coronary atherosclerosis progression, elevated HDL, decreased triglycerides, and a better overall cholesterol-to-HDL balance. Additionally, replacing saturated fat with high-glycemic carbs raises the risk of heart disease, and substituting saturated fat with polyunsaturated fat increases the progression of coronary atherosclerosis.

The Hidden Dangers of High-Saturated-Fat Foods

If you follow the authors’ advice and increase your saturated fat intake, you may inadvertently increase your risk of cardiovascular disease. This is because many foods high in saturated fat, such as processed meats, are also high in sodium, nitrites, and heme iron, which are all linked to increased cardiovascular risk. For example, sodium can raise blood pressure, nitrites can form harmful compounds in the body, and heme iron can promote oxidative stress and inflammation. These factors can contribute to the development of atherosclerosis and other cardiovascular problems, regardless of the saturated fat content.

Bowden and Sinatra also argue that replacing saturated fat with high-glycemic carbohydrates can increase the risk of heart disease by 33%. They explain that high-glycemic carbohydrates such as white rice, white bread, and cereal raise your blood sugar quickly. Consuming a lot of carbs makes your body retain the saturated fatty acids you're consuming, which get stored instead of being used for energy. Meanwhile, your liver converts any additional carbohydrates you consume into extra saturated fats.

Does the Authors’ Claim Apply to Everyone?

The authors’ claim that replacing saturated fat with high-glycemic carbohydrates increases the risk of heart disease by 33% may not apply to everyone. In an academic paper, researchers explain that when you consume more calories than you burn, your body stores the excess as fat. However, a study using a tracer to track the fate of starch in the body found that when people consumed a high-starch meal, most of the starch was burned for energy or stored as glycogen, with only a small amount converted to fat. This suggests that the authors’ claim may not apply to people who don’t consume more calories than they burn.

Advanced Indicators of Cardiovascular Well-Being and Effective Prevention

Bowden and Sinatra argue that advanced markers can help assess heart and blood vessel risks and guide prevention strategies. These markers include F2-isoprostanes (also called F2-IsoPs), myeloperoxidase (MPO), oxidized LDL (oxLDL), and Lp-PLA2. They explain that F2-IsoPs are by-products of oxidative and inflammatory processes, and they constrict arteries and facilitate coagulation. MPO is an inflammatory enzyme released in the arteries, and it indicates how prone your plaque is to rupture. OxLDL is cholesterol altered by oxidation, and it initiates atherosclerosis. Lp-PLA2 is an enzyme made by inflamed plaque that indicates how prone plaque is to rupture.

Guidelines on Advanced Blood Tests

The American College of Cardiology and American Heart Association (Arnett et al., 2019) recommend against using most novel blood tests to screen for heart disease risk. They argue that these tests rarely change treatment decisions beyond standard risk factors. Instead, they suggest considering only a few specific markers—high-sensitivity C-reactive protein, lipoprotein(a), apolipoprotein B, fasting triglycerides, and the ankle–brachial index—in certain adults when the decision about preventive medication is unclear after standard risk assessment.